Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 83

1.

Increased total cytokeratin-18 serum and urine levels in chronic kidney disease.

Roth GA, Lebherz-Eichinger D, Ankersmit HJ, Hacker S, Hetz H, Vukovich T, Perne A, Reiter T, Farr A, Hörl WH, Haas M, Krenn CG.

Clin Chim Acta. 2011 Apr 11;412(9-10):713-7. doi: 10.1016/j.cca.2010.12.030. Epub 2010 Dec 31.

PMID:
21195700
[PubMed - indexed for MEDLINE]
2.

Total and caspase-cleaved cytokeratin 18 in chronic cholecystitis: a prospective study.

Simopoulos C, Tsaroucha AK, Asimakopoulos B, Giatromanolaki A, Gavriilidis P, Polychronidis A, Karayiannakis A.

BMC Gastroenterol. 2008 May 6;8:14. doi: 10.1186/1471-230X-8-14.

PMID:
18460214
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Serum biomarkers of cell death for monitoring therapy response of gastrointestinal carcinomas.

Brandt D, Volkmann X, Anstätt M, Länger F, Manns MP, Schulze-Osthoff K, Bantel H.

Eur J Cancer. 2010 May;46(8):1464-73. doi: 10.1016/j.ejca.2010.01.037. Epub 2010 Mar 2.

PMID:
20202824
[PubMed - indexed for MEDLINE]
4.

Elevated serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) in patients with nonalcoholic steatohepatitis and chronic hepatitis C.

Yilmaz Y, Dolar E, Ulukaya E, Akgoz S, Keskin M, Kiyici M, Yerci O, Oral AY, Gul CB, Gurel S, Nak SG, Gulten M.

Med Sci Monit. 2009 Apr;15(4):CR189-93.

PMID:
19333204
[PubMed - indexed for MEDLINE]
5.

Caspase-cleaved fragments of cytokeratin 18 in patients with chronic hepatitis B.

Eren F, Yilmaz Y, Kose S, Ozdemir FT, Yonal O, Kurt R, Ozdogan O, Avsar E.

Clin Chim Acta. 2010 Dec 14;411(23-24):2029-32. doi: 10.1016/j.cca.2010.08.035. Epub 2010 Aug 31.

PMID:
20807521
[PubMed - indexed for MEDLINE]
6.

Caspase-cleaved cytokeratin 18 and 20 S proteasome in liver degeneration.

Hetz H, Hoetzenecker K, Hacker S, Faybik P, Pollreisz A, Moser B, Roth G, Hoetzenecker W, Lichtenauer M, Klinger M, Krenn CG, Ankersmit HJ.

J Clin Lab Anal. 2007;21(5):277-81.

PMID:
17847110
[PubMed - indexed for MEDLINE]
7.

Cell death serum biomarkers are early predictors for survival in severe septic patients with hepatic dysfunction.

Hofer S, Brenner T, Bopp C, Steppan J, Lichtenstern C, Weitz J, Bruckner T, Martin E, Hoffmann U, Weigand MA.

Crit Care. 2009;13(3):R93. doi: 10.1186/cc7923. Epub 2009 Jun 18.

PMID:
19538738
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Increased soluble serum markers caspase-cleaved cytokeratin-18, histones, and ST2 indicate apoptotic turnover and chronic immune response in COPD.

Hacker S, Lambers C, Pollreisz A, Hoetzenecker K, Lichtenauer M, Mangold A, Niederpold T, Hacker A, Lang G, Dworschak M, Vukovich T, Gerner C, Klepetko W, Ankersmit HJ.

J Clin Lab Anal. 2009;23(6):372-9. doi: 10.1002/jcla.20348.

PMID:
19927353
[PubMed - indexed for MEDLINE]
9.

Serum apoptotic caspase activity in chronic hepatitis C and nonalcoholic Fatty liver disease.

Papatheodoridis GV, Hadziyannis E, Tsochatzis E, Georgiou A, Kafiri G, Tiniakos DG, Margariti K, Manolakopoulos S, Manesis EK, Archimandritis AJ.

J Clin Gastroenterol. 2010 Apr;44(4):e87-95. doi: 10.1097/MCG.0b013e3181c0945a.

PMID:
19881359
[PubMed - indexed for MEDLINE]
10.

HSP27 and HSP70 serum and urine levels in patients suffering from chronic kidney disease.

Lebherz-Eichinger D, Ankersmit HJ, Hacker S, Hetz H, Kimberger O, Schmidt EM, Reiter T, Hörl WH, Haas M, Krenn CG, Roth GA.

Clin Chim Acta. 2012 Jan 18;413(1-2):282-6. doi: 10.1016/j.cca.2011.10.010. Epub 2011 Oct 18.

PMID:
22032827
[PubMed - indexed for MEDLINE]
11.

Serum M30 levels are associated with survival in advanced gastric carcinoma patients.

Yaman E, Coskun U, Sancak B, Buyukberber S, Ozturk B, Benekli M.

Int Immunopharmacol. 2010 Jul;10(7):719-22. doi: 10.1016/j.intimp.2010.03.013. Epub 2010 Mar 31.

PMID:
20362077
[PubMed - indexed for MEDLINE]
12.

Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.

Schefold JC, Zeden JP, Fotopoulou C, von Haehling S, Pschowski R, Hasper D, Volk HD, Schuett C, Reinke P.

Nephrol Dial Transplant. 2009 Jun;24(6):1901-8. doi: 10.1093/ndt/gfn739. Epub 2009 Jan 20.

PMID:
19155537
[PubMed - indexed for MEDLINE]
Free Article
13.

Keratin 18 and heat-shock protein in chronic kidney disease.

Lebherz-Eichinger D, Krenn CG, Roth GA.

Adv Clin Chem. 2013;62:123-49. Review.

PMID:
24772666
[PubMed - indexed for MEDLINE]
14.

Soluble cytokeratin 18 biomarkers may provide information on the type of cell death during early ischemia and reperfusion periods of liver transplantation.

Ulukaya S, Ulukaya E, Alper I, Yilmaztepe-Oral A, Kilic M.

Clin Transplant. 2010 Nov-Dec;24(6):848-54. doi: 10.1111/j.1399-0012.2009.01177.x.

PMID:
20030677
[PubMed - indexed for MEDLINE]
15.

Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.

Papatheodoridis GV, Hadziyannis E, Tsochatzis E, Chrysanthos N, Georgiou A, Kafiri G, Manolakopoulos S, Tiniakos DG, Giannousis I, Manesis EK, Archimandritis AJ.

Gut. 2008 Apr;57(4):500-6. Epub 2007 Nov 19.

PMID:
18025069
[PubMed - indexed for MEDLINE]
16.

Caspase-cleaved cytokeratin 18 fragment (M30) as marker of postoperative residual tumor load in colon cancer patients.

Ausch C, Buxhofer-Ausch V, Olszewski U, Hinterberger W, Ogris E, Schiessel R, Hamilton G.

Eur J Surg Oncol. 2009 Nov;35(11):1164-8. doi: 10.1016/j.ejso.2009.02.007. Epub 2009 Feb 28.

PMID:
19254831
[PubMed - indexed for MEDLINE]
17.

Clinical evaluation of M30 and M65 ELISA cell death assays as circulating biomarkers in a drug-sensitive tumor, testicular cancer.

de Haas EC, di Pietro A, Simpson KL, Meijer C, Suurmeijer AJ, Lancashire LJ, Cummings J, de Jong S, de Vries EG, Dive C, Gietema JA.

Neoplasia. 2008 Oct;10(10):1041-8.

PMID:
18813353
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Circulating cell death products predict clinical outcome of colorectal cancer patients.

Koelink PJ, Lamers CB, Hommes DW, Verspaget HW.

BMC Cancer. 2009 Mar 23;9:88. doi: 10.1186/1471-2407-9-88.

PMID:
19302716
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

High Mobility Group Box Protein-1 correlates with renal function in chronic kidney disease (CKD).

Bruchfeld A, Qureshi AR, Lindholm B, Barany P, Yang L, Stenvinkel P, Tracey KJ.

Mol Med. 2008 Mar-Apr;14(3-4):109-15. doi: 10.2119/2007-00107.Bruchfeld.

PMID:
18317568
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Endothelin-1, big endothelin-1, and nitric oxide in patients with chronic renal disease and hypertension.

Mikulić I, Petrik J, Galesić K, Romić Z, Cepelak I, Zeljko-Tomić M.

J Clin Lab Anal. 2009;23(6):347-56. doi: 10.1002/jcla.20324.

PMID:
19927348
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk